Positron, a molecular imaging medical devices developer, has introduced the NeuSight PET-CT 3D 64 slice scanner for cardiac imaging in the US and North American markets.
The NeuSight PET-CT technology is designed for nuclear cardiology practices and hospitals.
According to the US-based Positron, the new scanner advances imaging and diagnostic accuracy, patient comfort, and operational efficiency.
NeuSight is designed to transform cardiac positron emission tomography (PET) imaging.
The imaging medical devices manufacturer claimed that the PET-CT scanners have been installed globally.
NeuSight PET-CT is manufactured by China-based Neusoft Medical Systems.
Under a business cooperation agreement, Positron holds exclusive rights to sell and distribute the scanner in the North American market through Neusoft Medical Systems’ subsidiary, Shenyang Intelligent Nuclear Medical Technology.
NeuSight PET-CT is suitable for clinical studies in cardiology and oncology. It is said to have superior data acquisition capabilities with advanced identification technology that enhances scanning speed and accuracy.
The system delivers both anatomic and functional imaging to support various molecular imaging functions for heart, tumour, and brain imaging trials.
Its detector modules feature scintillating crystals to enhance photoelectric conversion efficiency, sensitivity, and temporal resolution.
In addition, the system’s proprietary IPIE technology further improves spatial resolution and data accuracy.
Other key features include a clear honeycomb and patented asymmetrical light-guided technology that offers more image clarity and resolution, crucial for cardiac diagnostics.
Additionally, the NeuSight PET-CT includes advanced clinical applications such as 4D Gate capabilities for precise attenuation correction, image fusion optimisation, and quality control procedures.
Furthermore, it features a spacious 72cm gantry and high-sensitivity acquisition technology that ensures safety with minimal radiation exposure for both patients and technicians.
It also has the smallest footprint and lightest weight of any PET-CT 64-slice system available in the industry, Positron claimed.
Positron president Adel Abdullah said: “We are excited to bring the NeuSight PET-CT to imaging practices and hospitals serving both segment of nuclear cardiology and oncology imaging.
“This marks a significant milestone for Positron as it enters the PET-CT market at an opportune time to meet an increased demand in nuclear cardiology driven by advancements in technology and a favourable reimbursement environment for PET-CT technology.”
